MULINACCI, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 251
NA - Nord America 96
AS - Asia 44
Totale 391
Nazione #
IT - Italia 111
US - Stati Uniti d'America 93
DE - Germania 51
IE - Irlanda 39
HK - Hong Kong 22
SE - Svezia 17
CN - Cina 16
GB - Regno Unito 13
FI - Finlandia 7
CA - Canada 3
ES - Italia 3
IN - India 3
NL - Olanda 3
GR - Grecia 2
AT - Austria 1
CH - Svizzera 1
EE - Estonia 1
FR - Francia 1
IQ - Iraq 1
JP - Giappone 1
LK - Sri Lanka 1
RU - Federazione Russa 1
Totale 391
Città #
Frankfurt am Main 47
Milan 42
Dublin 38
New York 18
Hong Kong 16
London 10
Shanghai 10
Ashburn 7
Beijing 6
Central 6
Helsinki 6
Monza 6
Rome 6
Chandler 5
Naples 5
Chicago 4
Princeton 4
Ann Arbor 3
Boardman 3
Carate Brianza 3
Cossato 3
Florence 3
Los Angeles 3
Modena 3
Acquaviva delle Fonti 2
Alzano Lombardo 2
Assago 2
Athens 2
Bari 2
Cary 2
Catania 2
Cirié 2
Fairfield 2
Huizen 2
Lawrence 2
Mumbai 2
Seville 2
Sovico 2
Taranto 2
Vimercate 2
Washington 2
Andover 1
Atlanta 1
Belsize Park 1
Bonndorf 1
Bristol 1
Caronno Pertusella 1
Castiglione del Lago 1
Cesano Maderno 1
Council Bluffs 1
Dambulla 1
Dottingen 1
Foggia 1
Garbagnate Milanese 1
Genoa 1
Groningen 1
Hounslow 1
Houston 1
Jasper 1
Kemerovo 1
Lappeenranta 1
Lentate sul Seveso 1
Madinat Babil 1
Marcallo con Casone 1
Medolago 1
Montrouge 1
Padova 1
Pune 1
Richterswil 1
San Biagio di Callalta 1
San Diego 1
Seattle 1
Tallinn 1
Tappahannock 1
Terni 1
Tokyo 1
Tomares 1
Toronto 1
Treviso 1
Trois-Rivières 1
Turin 1
Verona 1
Vienna 1
Windsor 1
Totale 334
Nome #
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 118
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 72
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 57
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 54
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 40
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 28
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis 22
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 18
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 3
Totale 412
Categoria #
all - tutte 2.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 0 0 0 0 0 0 9 3 0 2 3
2022/2023201 6 11 14 21 40 37 13 11 10 13 9 16
2023/2024194 7 14 19 28 29 39 30 3 16 9 0 0
Totale 412